XML 46 R30.htm IDEA: XBRL DOCUMENT v3.8.0.1
Fair Value Measurements (Tables)
3 Months Ended
Mar. 31, 2018
Fair Value Disclosures [Abstract]  
Schedule of assets and liabilities measured at fair value on a recurring basis
The following tables represent the fair value hierarchy as of March 31, 2018 and December 31, 2017, for those assets and liabilities that we measure at fair value on a recurring basis (in thousands):
 
Fair Value Measurements at March 31, 2018 Using:
 
 
 
Quoted Prices in
 
 
 
Significant
 
 
 
Active Markets for
 
Significant Other
 
Unobservable
 
 
 
Identical Assets
 
Observable Inputs
 
Inputs
 
Total
 
(Level 1)
 
(Level 2)
 
(Level 3)
Assets:
 
 
 
 
 
 
 
Cash equivalents
$
2,255

 
$
2,255

 
$

 
$

Corporate debt securities
110,450

 

 
110,450

 

U.S. treasury and government agency securities
12,258

 

 
12,258

 

Certificates of deposit
10,150

 
 
 
10,150

 

Commercial paper
$
5,962

 
$

 
$
5,962

 
$

Total Assets
$
141,075

 
$
2,255

 
$
138,820

 
$

Liabilities:
 

 
 

 
 

 
 

Contingent consideration - Lumara Health
$
49,797

 
$

 
$

 
$
49,797

Contingent consideration - MuGard
870

 

 

 
870

Total Liabilities
$
50,667

 
$

 
$

 
$
50,667

 
 
Fair Value Measurements at December 31, 2017 Using:
 
 
 
Quoted Prices in
 
 
 
Significant
 
 
 
Active Markets for
 
Significant Other
 
Unobservable
 
 
 
Identical Assets
 
Observable Inputs
 
Inputs
 
Total
 
(Level 1)
 
(Level 2)
 
(Level 3)
Assets:
 
 
 
 
 
 
 
Cash equivalents
$
4,591

 
$
4,591

 
$

 
$

Corporate debt securities
116,152

 

 
116,152

 

U.S. treasury and government agency securities
9,291

 

 
9,291

 

Certificates of deposit
9,151

 

 
9,151

 

Commercial paper
1,999

 

 
1,999

 

Total Assets
$
141,184

 
$
4,591

 
$
136,593

 
$

Liabilities:
 
 
 
 
 
 
 
Contingent consideration - Lumara Health
$
49,187

 
$

 
$

 
$
49,187

Contingent consideration - MuGard
898

 

 

 
898

Total Liabilities
$
50,085

 
$

 
$

 
$
50,085

Schedule of reconciliation of contingent consideration obligations
The following table presents a reconciliation of contingent consideration obligations related to the acquisition of Lumara Health (related to our Makena product) and the MuGard Rights (in thousands):
Balance as of December 31, 2017
$
50,085

Payments made
(44
)
Adjustments to fair value of contingent consideration
626

Balance as of March 31, 2018
$
50,667